No Detail Found!

Assessment of left ventricular hypertrophy incidence and antihypertensive therapy efficacy in hypertensive patients

Author(s)
Samia Perwaiz Khan JMDC, Sohail University,Karachi,Pakistan
Harris Majeed JMDC, Sohail University,Karachi,Pakistan
Safia Izhar JMDC, Sohail University,Karachi,Pakistan
Shaista Kanwal JMDC, Sohail University,Karachi,Pakistan
Raeeqah Ahmed JMDC, Sohail University,Karachi,Pakistan
Rimsha Munawar JMDC, Sohail University,Karachi,Pakistan
Somal Meraj JMDC, Sohail University,Karachi,Pakistan
Laiba Naz JMDC, Sohail University,Karachi,Pakistan
Abstract
Objectives: This study aimed to assess the incidence of left ventricular hypertrophy (LVH) in hypertensive individuals in Karachi, Pakistan, and to evaluate the effectiveness of antihypertensive therapy in preventing LVH. Methodology: A total of 200 hypertensive patients were referred from the Cardiac OPD to the Radiology department of Medicare Cardiac and General Hospital, Karachi, for echocardiography. Echocardiographic measurements of cardiac chambers were performed by expert echocardiographers, and left ventricular mass (LVM) was calculated using the formula recommended by the American Society of Echocardiography. Results: Among the hypertensive patients, 100 had uncontrolled blood pressure (=140/90 mmHg) while 100 had controlled blood pressure (=130/80 mmHg). The female-to-male ratio was 3:1, with ages ranging from 21 to 80 years. Patients with uncontrolled hypertension exhibited a higher mean body mass index (29 ± 5 kg/m2) and significantly elevated LVM (mean 154 ± 4 g/m2). Angiotensin receptor inhibitors were the most commonly prescribed and effective antihypertensive agents, either as monotherapy or in combination therapy (60%), demonstrating utility in preventing LVH. Conclusion: This study highlights a high incidence of LVH in uncontrolled hypertensive individuals compared to those with controlled hypertension. Transthoracic echocardiography emerged as a highly valuable, non-invasive tool for measuring LVM and assessing the effectiveness of antihypertensive therapy.
Publication Details
Page(s) 18-22
Published Journal: Pakistan Heart Journal, Volume: 57, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
Left ventricular hypertrophy, echocardiography, ACE inhibitors, left ventricular mass, relative wall thickness
References
WS Aronow .2017 .Hypertension and left ventricular hypertrophy. Ann Transl Med, 5(15) : 310.
Johnson K,Oparil S,Davis BR,Tereshchenko LG .2019 .Prevention of heart failure in hypertension-disentangling the role of evolving left ventricular hypertrophy and blood pressure lowering: the ALLHAT study. J Am Heart Assoc, 8(8) : e011961.
Marian AJ,Braunwald E. .2017 .Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res, 121(7) : 749-70.
.2021 .. , : CD012039.
Princ Pract Med .2022 .. , 31(5) : 454-62.
Okin PM,Devereux RB,Jern S,Kjeldsen SE,Julius S,Nieminen MS .2004 .Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA, 292(19) : 2343-9.
Hypertension .2019 .. , 73(3) : 612-9.
.2022 .Echocardiographic Parameters of Pakistani Adults with Normal Echocardiogram. Pak Heart J, 55(2) : 191-5.
Lee JH,Park JH .2015 .Role of echocardiography in clinical hypertension. Clin Hyperten, 21 : 1-1.
Zhang W,Zhou Y,Bai B,Yu S,Xiong J,Chi C .2019 .Consistency of left ventricular hypertrophy diagnosed by electrocardiography and echocardiography: the Northern Shanghai Study. Clin Interv Aging, 14 : 549-56.
.2017 .. , 10(8) : e003959.
Kinno M,Waller A,Gardin J .2016 .Approaches to echocardiographic assessment of left ventricular mass what does echocardiography add. Am J Card, : 1-9.
Marwick TH,Gillebert TC,Aurigemma G,Chirinos J,Derumeaux G,Galderisi M .2015 .Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). Eur Heart J Cardiovasc Imaging, 16(6) : 577-605.
Wang Y,Zhou R,Lu C,Chen Q,Xu T,Li D. .2019 .Effects of the angiotensin‐receptor neprilysin inhibitor on cardiac reverse remodeling: meta‐analysis. J Am Heart Assoc, 8(13) : e012272.
Messerli FH,Bangalore S,Bavishi C,Rimoldi SF .2018 .Angiotensinconverting enzyme inhibitors in hypertension: to use or not to use?. J Am Coll Cardiol, 71(13) : 1474-82.
Barbieri A,Bursi F,Camaioni G,Maisano A,Imberti JF,Albini A .2021 .Echocardiographic left ventricular mass assessment: correlation between 2D-derived linear dimensions and 3- dimensional automated, machine learning-based methods in unselected patients. J Clin Med, 10(6) : 1279.
Jia G,Aroor AR,Hill MA,Sowers JR .2018 .Role of renin-angiotensinaldosterone system activation in promoting cardiovascular fibrosis and stiffness. Hypertension, 72(3) : 537-48.
Jekell A,Nilsson PM,Kahan T. .2018 .Treatment of hypertensive left ventricular hypertrophy. Curr Pharm Des, 24(37) : 4391-6.
Horsa BA,Tadesse Y,Engidawork E .2019 .Assessment of hypertension control and factors associated with the control among hypertensive patients attending at Zewditu Memorial Hospital: a cross sectional study. BMC Res Notes, 12 : 1-6.
Izzo R,Losi MA,Stabile E,Lönnebakken MT,Canciello G,Esposito G .2017 .Development of left ventricular hypertrophy in treated hypertensive outpatients: the Campania Salute Network. Hypertension, 69(1) : 136-42.
Asch FM,Banchs J,Price R,Rigolin V,Thomas JD,Weissman NJ .2019 .Need for a global definition of normative echo valuesrationale and design of the World Alliance of Societies of Echocardiography Normal Values Study (WASE). J Am Soc Echocardiogr, 32(1) : 157-62.
Yildiz M,Oktay AA,Stewart MH,Milani RV,Ventura HO,Lavie CJ .2020 .Left ventricular hypertrophy and hypertension. Prog Cardiovasc Dis, 63(1) : 10-21.
Roush GC,Abdelfattah R,Song S,Ernst ME,Sica DA,Kostis JB .2018 .Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium‐sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: a systematic review and meta‐analysis. J Clin Hypertens, 20(10) : 1507-15.
Salvetti M,Paini A,Bertacchini F,Stassaldi D,Aggiusti C,Rosei CA .2018 .Changes in left ventricular geometry during antihypertensive treatment. Pharmacol Res, 134 : 193-9.
Ahmed SN,Jhaj R,Sadasivam B,Joshi R .2020 .Regression of the Left Ventricular Hypertrophy in Patients with Essential Hypertension on Standard Drug Therapy. Discoveries, 8(3) : e115.
0

Citations

1

Downloads

115

Views